Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

56.42 +0.25 (+0.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,213,345
Open 56.38
Bid (Size) 55.00 (1)
Ask (Size) 56.05 (4)
Prev. Close 56.17
Today's Range 55.55 - 57.70
52wk Range 39.97 - 72.83
Shares Outstanding 171,948,769
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EXAS Q1 Earnings Call: Outperformance Driven by Commercial Execution, New Products, and Margin Expansion
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) announced better-than-expected revenue in Q1 CY2025, with sales up 10.9% year on year to $706.8 million. The company’s full-year revenue... 
Via StockStory
1 Healthcare Stock Worth Investigating and 2 to Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities

Performance

YTD
-0.9%
-0.9%
1 Month
+33.5%
+33.5%
3 Month
+14.4%
+14.4%
6 Month
+14.4%
+14.4%
1 Year
+8.6%
+8.6%

More News

Read More
2 Brilliant Stocks to Buy With $200 and Hold for 5 Years
Via The Motley Fool
Exact Sciences Earns 2025 Great Place To Work® Certification™
From Exact Sciences Corp.
Via Business Wire
Earnings Scheduled For May 1, 2025
Via Benzinga
Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
Via Benzinga
Exact Sciences (EXAS) Stock Trades Up, Here Is Why
Via StockStory
Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday
Via Benzinga
Cancer Diagnostic Firm Exact Sciences' CEO Says Strong Q1 Paves Way For 'Transformative' 2025, Lifts Annual Guidance
Via Benzinga
Exact Sciences to Participate in May Investor Conference
From Exact Sciences Corp.
Via Business Wire
Why Twilio Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Exact Sciences (NASDAQ:EXAS) Posts Better-Than-Expected Sales In Q1, Stock Soars
Via StockStory
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Exact Sciences Hikes Its Full-Year Outlook. But There's One First-Quarter Drawback.
Via Investor's Business Daily
Topics Government
Exposures Political
Exact Sciences Announces First-Quarter 2025 Results
From Exact Sciences Corp.
Via Business Wire
Exact Sciences (EXAS) Reports Q1: Everything You Need To Know Ahead Of Earnings
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025
From Exact Sciences Corp.
Via Business Wire
2 Reasons to Like EXAS (and 1 Not So Much)
Via StockStory
Exact Sciences Launches New Test To Monitor Cancer Recurrence: Retail’s Optimistic
Via Stocktwits
Topics Government
Exposures Political
Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test
From Exact Sciences Corp.
Via Business Wire
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
Via Investor's Business Daily
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups
From Exact Sciences Corp.
Via Business Wire
Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Oversold Stocks Ready to Bounce Back and 1 to Approach with Caution
Via StockStory

Frequently Asked Questions

Is Exact Sciences Corporation - Common Stock publicly traded?
Yes, Exact Sciences Corporation - Common Stock is publicly traded.
What exchange does Exact Sciences Corporation - Common Stock trade on?
Exact Sciences Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exact Sciences Corporation - Common Stock?
The ticker symbol for Exact Sciences Corporation - Common Stock is EXAS on the Nasdaq Stock Market
What is the current price of Exact Sciences Corporation - Common Stock?
The current price of Exact Sciences Corporation - Common Stock is 56.42
When was Exact Sciences Corporation - Common Stock last traded?
The last trade of Exact Sciences Corporation - Common Stock was at 05/16/25 04:00 PM ET
What is the market capitalization of Exact Sciences Corporation - Common Stock?
The market capitalization of Exact Sciences Corporation - Common Stock is 9.70B
How many shares of Exact Sciences Corporation - Common Stock are outstanding?
Exact Sciences Corporation - Common Stock has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.